A single number can pivot a patient’s trajectory from silent deterioration to timely rescue. Critical laboratory results and diagnoses—values or findings that imply imminent danger—are only as safe as the systems that surface them to the right clinician, fast, with proof of receipt and action. Drawing on multi-country surveys, quasi-experimental implementations, and outpatient and ICU studies, this article synthesizes how threshold design, communication channels, closed-loop automation, and therapeutic drug monitoring (TDM) converge to determine patient safety outcomes. The evidence shows that harmonized terminology, context-sensitive alert limits, and closed-loop, EMR-integrated escalation reduce misses and shorten time-to-treatment, improving measurable endpoints, including 48-hour mortality after discharge alerts. The argument is simple: in critical result management, minutes are a modifiable harm vector (Parl et al., 2010; Campbell & Horvath, 2014; Laguna et al., 2021; Harris et al., 2020; Wu et al., 2025).
A two-world hook: It is lunch hour. A hyperkalemia result clears the analyzer. In World A, the lab phones the admitting physician; lines are busy, the “read-back” stumbles, and the callback loops during shift bottlenecks. In World B, a closed-loop alert hits the responsible clinician’s device; if unacknowledged in minutes, escalation is automatic; every hop is auditable in the EMR. In World A, minutes accumulate and risk compounds. In World B, confirmation times fall below three minutes and treatment starts while risk is still potential, not actual harm (Parl et al., 2010; Harris et al., 2020).
Why definitions and governance matter: “Critical values,” “critical results,” “panic” or “alarm” results, and “critical diagnoses” are often used inconsistently, yet accreditation requires timely, reliable notification with read-back and traceability (ISO 15189; Joint Commission). A harmonization agenda clarifies terms, separates critical tests from critical results, and frames measurable performance specifications, reducing preventable failure modes across the post-analytical phase (Campbell & Horvath, 2014; Piva et al., 2017; Piva et al., 2015).
Patient-safety signal: what the data actually show: Heterogeneity is not harmless. A national Danish survey found approximately one out of ten critical results went unreported, with limited monitoring of reporting timeframes—an overt patient-safety exposure (Fauro et al., 2024). In Turkey, delays clustered at morning peaks, lunch breaks, and end-of-day, especially for ward and clinic orders; 13.1 percent of notifications were delayed, with non-physician recipients predominating—another safety gap (Özcan et al., 2017). Process tweaks can be powerful: replacing the “admitting physician” with the “most recent note writer” as the first-call target reduced five-minute read-back failures from 49.5 percent to 31.3 percent (Harris et al., 2020). Outpatient pathways are harder to reach but pay off; in Spain, biochemistry criticals triggered appropriate action in 49 percent of outpatients, and tuning glucose thresholds by diabetes status improved protocol effectiveness (Laguna et al., 2021).
Threshold design: from one size fits all to context-aware: A single institutional threshold suffices for some physiologic hazards (for example, profound hypoglycemia, severe acidosis), but most analytes demand nuance. Hematology critical limits for hemoglobin, leukocytes, platelets, and INR diverge by clinical area and age group; large surveys underscore both the need and the reality of population-specific thresholds (Schapkaitz & Levy, 2015; Keng et al., 2016). For coagulation, platform-dependent variability is decisive: APTT “critical” limits should be reagent- and instrument-specific to avoid misclassification and downstream harm (Huang et al., 2024). National audits likewise report persistent inter-laboratory variability, reinforcing the need for clinician–laboratory consensus and periodic review (Zeng et al., 2013; Arbiol-Roca et al., 2019).
Beyond chemistry: critical diagnoses and judicious alerting: Anatomic pathology carries its own category—“critical diagnoses”—that warrant urgent clinician contact; lists should be locally customized and templated by specialty societies (Silverman et al., 2006). Not every case merits a call: when the EMR documents a non-emergency state (for example, no products of conception with a confirmed intrauterine pregnancy), deferring “critical” status appropriately preserves channel capacity for true threats (Renshaw, 2012).
Therapeutic drug monitoring: the most fragile window: TDM concentrates risk where therapeutic and toxic ranges nearly touch. In a large two-year dataset, vancomycin troughs accounted for 63.4 percent of TDM criticals, followed by tacrolimus and digoxin, with clustering in general ICU, cardiology, and surgical ICU (Xiao et al., 2024). At the time of critical results, BUN, creatinine, NT-proBNP, and lymphocyte percentage differed significantly between drug groups, implying that thresholds and urgency should be interpreted against renal function, cardiac load, and immune status, not as isolated numbers (Xiao et al., 2024). In practice, that means closed-loop alerts and escalation rules tied to service lines and organ function, not generic paging trees (Piva et al., 2017; Parl et al., 2010).
What to standardize and what to localize: Standardize the language, the minimum dataset for notifications, the read-back requirement, and time-to-acknowledgment/treatment targets. Localize the thresholds by population (neonate, pediatric, adult), pathology (for example, coagulopathy), platform (for example, APTT systems), and service context (for example, ER as “critical tests” to avoid alert fatigue), reviewed at set intervals with KPI dashboards. When governance aligns with technology, misses fall and outcomes improve (Campbell & Horvath, 2014; Piva et al., 2015; ALFadhalah et al., 2022).
Implementation blueprint: Begin with a gap assessment against ISO 15189 and Joint Commission elements, using local data on delayed notifications, misses, and read-back failures (Dighe et al., 2006; Özcan et al., 2017). Stand up closed-loop alerting integrated with the EMR and directory services; define escalation within minutes, not hours (Parl et al., 2010; Wu et al., 2025). Re-baseline thresholds by analyte and population in partnership with clinical leads; make platform-specific exceptions explicit (Keng et al., 2016; Huang et al., 2024). For outpatients, embed recall pathways with monitored outcomes (Laguna et al., 2021; Chang et al., 2022). Publish a KPI set—acknowledgment median, read-back compliance, time-to-treatment, seven-day return, 48-hour mortality—for monthly governance and service-level feedback (Piva et al., 2017; ALFadhalah et al., 2022).
Conclusion: minutes as a moral choice: The split screen between World A and World B is not hypothetical; it is a decision about language, thresholds, channels, and accountability. The literature is consistent: heterogeneity and phone-only processes create avoidable harm; closed-loop systems, context-sensitive thresholds, and monitored KPIs convert time into safety (Fauro et al., 2024; Parl et al., 2010; Wu et al., 2025; Harris et al., 2020). In critical result management, engineering is ethics by other means.
References
ALFadhalah, T., Al Mudaf, B., Al Tawalah, H., Al Fouzan, W. A., Al Salem, G., Alghanim, H. A., Ibrahim, S. Z., Elamir, H., & Al Kharji, H. (2022). Baseline assessment of staff perception of critical value practices in government hospitals in Kuwait. BMC Health Services Research, 22(1), 1–14. https://doi.org/10.1186/s12913-022-08329-z
Arbiol-Roca, A., Corral-Comesaña, S., Cano-Corres, R., José Castro-Castro, M., Dastis-Arias, M., & Dot-Bach, D. (2019). Analysis of laboratory critical values at a referral Spanish tertiary university hospital. Biochemia Medica, 29(1), Article 010704. https://doi.org/10.11613/BM.2019.010704
Campbell, C. A., & Horvath, A. R. (2014). Harmonization of critical result management in laboratory medicine. Clinica Chimica Acta, 432, 135–147. https://doi.org/10.1016/j.cca.2013.11.004
Chang, H.-T., Kuo, S.-F., Chen, S.-H., Lin, J.-S., Lin, S.-H., Chang, C.-F., Twu, C.-W., Chen, M.-C., Yang, Y.-T., Kor, C.-T., Lin, C.-H. (2022). Critical Test Result Recall Supporting System (CTR RSS) improves follow-up among patients in the community. Diagnostics, 12(5), 1252. https://doi.org/10.3390/diagnostics12051252
Dighe, A. S., Rao, A., Coakley, A. B., & Lewandrowski, K. B. (2006). Analysis of laboratory critical value reporting at a large academic medical center. American Journal of Clinical Pathology, 125(5), 758–764. https://doi.org/10.1309/R53XVC2U5CH6TNG8
Fauro, K. K., Antonsen, S., & Nybo, M. (2024). Critical test result management at Danish hospital laboratories: A national survey. Scandinavian Journal of Clinical & Laboratory Investigation, 84(3), 174–182. https://doi.org/10.1080/00365513.2024.2343906
Harris, S., Leech, W., Matienzo, D., Villanueva, S. B., Fogel, J., Tetrokalashvili, M., & Riggs, J. (2020). Improving critical value read-back failure rate by modifying the notification procedure. Southern Medical Journal, 113(3), 130–133. https://doi.org/10.14423/SMJ.0000000000001073
Huang, H. L., Qu, T. J., …, & Mo, X. M. (2024). APTT critical value establishment in four different reagent/instrument systems based on single factor deficiencies. Annals of Hematology, 103(8), 3219–3227. https://doi.org/10.1007/s00277-024-05972-0
Keng, T. B., De La Salle, B., Bourner, G., Merino, A., Han, J.-Y., Kawai, Y., Peng, M. T., & McCafferty, R. (2016). Standardization of haematology critical results management in adults: An ICSH survey and recommendations. International Journal of Laboratory Hematology, 38(5), 457–471. https://doi.org/10.1111/ijlh.12526
Laguna, J., Macias-Muñoz, L., Bedini, J. L., & Rico, N. (2021). Notification of biochemistry critical results and its clinical impact on outpatient care: Experience in a Spanish tertiary hospital. Clinical Chemistry and Laboratory Medicine, 59(11), 1777–1783. https://doi.org/10.1515/cclm-2021-0495
Özcan, O., Çakırça, G., Motor, S., & Yönden, Z. (2017). Delays in reporting critical values from clinical laboratories to responsible healthcare staff. Turkish Journal of Biochemistry, 42(1), 45–50. https://doi.org/10.1515/tjb-2016-0249
Parl, F. F., O’Leary, M. F., Kaiser, A. B., Paulett, J. M., Statnikova, K., & Shultz, E. K. (2010). Implementation of a closed-loop reporting system for critical values and clinical communication in compliance with goals of The Joint Commission. Clinical Chemistry, 56(3), 417–423. https://doi.org/10.1373/clinchem.2009.135376
Piva, E., Pelloso, M., Penello, L., & Plebani, M. (2014). Laboratory critical values: Automated notification supports effective clinical decision making. Clinical Biochemistry, 47(13–14), 1163–1168. https://doi.org/10.1016/j.clinbiochem.2014.05.056
Piva, E., Sciacovelli, L., Pelloso, M., & Plebani, M. (2017). Performance specifications of critical results management. Clinical Biochemistry, 50(10–11), 617–621. https://doi.org/10.1016/j.clinbiochem.2017.05.010
Piva, E., Sciacovelli, L., Zaninotto, M., Laposata, M., & Plebani, M. (2009). Evaluation of effectiveness of a computerized notification system for reporting critical values. American Journal of Clinical Pathology, 131(3), 432–441. https://doi.org/10.1309/AJCPYS80BUCBXTUH
Renshaw, A. (2012). Using the electronic medical record to better define no products of conception as a critical value in anatomic pathology. American Journal of Clinical Pathology, 137(1), 121–123. https://doi.org/10.1309/AJCPRHYY29CYVODD
Schapkaitz, E., & Levy, B. (2015). Critical limits for urgent clinician notification at South African intensive care units. International Journal of Laboratory Hematology, 37(5), 620–625. https://doi.org/10.1111/ijlh.12373
Silverman, J. F., LiVolsi, V., Fletcher, C. D. M., Frable, W. J., Goldblum, J. R., Pereira, T. C., & Swanson, P. E. (2006). Critical diagnoses (critical values) in anatomic pathology. Human Pathology, 37(8), 982–984. https://doi.org/10.1016/j.humpath.2006.03.001
Wu, D., Zhu, F., Sheng, Y., Zhang, W., Le, H., Zhang, G., Wang, L., & Yan, B. (2025). Development and evaluation of a whole-chain management system for critical value reporting. BMC Medical Informatics and Decision Making, 25(1), Article 2936. https://doi.org/10.1186/s12911-025-02936-6
Xiao, Y., Xu, L., Qian, Y., & Xu, Y. (2024). Identification and characterization of critical values in therapeutic drug monitoring: A retrospective analysis. Scientific Reports, 14(1), 241. https://doi.org/10.1038/s41598-024-62402-7